Informaçao sobre o Autor

Криворотько, П. В

Edição Seção Título Arquivo
Nº 1S (2009) Articles ANTIANGIOGENNYE PREPARATY V LEChENII RAKA MOLOChNOY ZhELEZY
Nº 18 (2012) Articles A new approach to the overcoming resistance to hormone therapy of breast cancer
Nº 17 (2013) Articles Znachenie molekulyarnykh markerov pri vybore neoad\"yuvantnoy khimioterapii mestno-rasprostranennogo raka molochnoy zhelezy
Nº 8 (2016) Articles NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
Nº 17 (2016) Articles TAXANES IN THE TREATMENT OF BREAST CANCER
Nº 17 (2017) Articles New possibilities of the treatment of breast cancer: microtubule inhibitors
Nº 7 (2018) Articles GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER
Nº 12 (2018) Articles Ways to improve efficiency of endocrino-therapy of breast cancer: new targeted cells, new therapeutic opportunities
Volume 27, Nº 7 (2020) Articles Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study
Volume 27, Nº 7 (2020) Articles Treatment of residual breast cancer
Volume 27, Nº 7 (2020) Articles Abemacyclib - new options for the treatment of hormone-positive metastatic breast cancer with CDK4/6 inhibitors
Volume 29, Nº 7 (2022) Articles Predictive and prognostic role of tumor-infiltrating lymphocytes (TILs) in early triple-negative breast cancer
Volume 29, Nº 7 (2022) Articles Treatment of HER2-positive early (minimal) breast cancer
Volume 29, Nº 11/12 (2022) Articles The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Volume 29, Nº 11/12 (2022) Articles Ixabepilone in the treatment of breast cancer

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies